# A Study of Postoperative Adjuvant Chemotherapy for Upper Urinary Urothelial Carcinoma With Lymphovascular Invasion

> **NCT04255771** · PHASE3 · UNKNOWN · sponsor: **Qinghua Xia,Prof** · enrollment: 200 (estimated)

## Conditions studied

- Chemotherapy Effect

## Interventions

- **DRUG:** Gemcitabine
- **DRUG:** Placebos

## Key facts

- **NCT ID:** NCT04255771
- **Lead sponsor:** Qinghua Xia,Prof
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-03-01
- **Primary completion:** 2023-03-01
- **Final completion:** 2023-06-01
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2020-02-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04255771

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04255771, "A Study of Postoperative Adjuvant Chemotherapy for Upper Urinary Urothelial Carcinoma With Lymphovascular Invasion". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04255771. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*